Homepage
Medication Guide
How to Use Rasagiline (Azilect)
Rasagiline (Azilect) is a selective and irreversible monoamine oxidase type B (MAO-B) inhibitor, which was first approved for marketing in the United States in 2006. This medication is indicated for t...
505
Thursday, November 13th, 2025, 11:49
Indications for Rasagiline (Azilect)
Rasagiline (Azilect) is a selective and irreversible monoamine oxidase type B (MAO-B) inhibitor. Since its approval by the U.S. FDA in 2006, it has become an important treatment option for Parkinson&#...
505
Thursday, November 13th, 2025, 11:37
How to Purchase Rasagiline (Azilect)
Rasagiline (Azilect) is a selective and irreversible monoamine oxidase type B (MAO-B) inhibitor, and an important medication for the treatment of Parkinson's disease.How to Purchase Rasagiline (Az...
504
Thursday, November 13th, 2025, 11:30
What Are the Side Effects of Resmetirom (Rezdiffra)?
Resmetirom (Rezdiffra) is the first thyroid hormone receptor-beta agonist approved by the U.S. FDA in 2024 through the accelerated approval pathway for the treatment of non-cirrhotic non-alcoholic ste...
507
Thursday, November 13th, 2025, 11:25
Precautions for Using Resmetirom (Rezdiffra)
Resmetirom (Rezdiffra) is a thyroid hormone receptor-beta (THR-β) agonist and the first targeted drug approved for the treatment of non-cirrhotic non-alcoholic steatohepatitis (NASH) with moderate to ...
511
Thursday, November 13th, 2025, 11:18
How to Use Resmetirom (Rezdiffra)
Resmetirom (Rezdiffra) is a thyroid hormone receptor-beta agonist approved for marketing by the U.S. FDA in 2024. When used in combination with diet and exercise, this medication is indicated for the ...
507
Thursday, November 13th, 2025, 11:16
Indications for Resmetirom (Rezdiffra)
Resmetirom (Rezdiffra) is a thyroid hormone receptor-beta agonist approved for marketing by the U.S. Food and Drug Administration (FDA) in 2024. When used in combination with diet and exercise, this m...
507
Thursday, November 13th, 2025, 11:08
How to Purchase Resmetirom (Rezdiffra)
Resmetirom (Rezdiffra) is the first drug approved by the U.S. FDA in 2024 for the treatment of non-cirrhotic non-alcoholic steatohepatitis (NASH). Its standardized acquisition and authenticity identif...
507
Thursday, November 13th, 2025, 11:03
What Are the Side Effects of Sabril (Vigabatrin)?
Sabril (Vigabatrin) is an antiepileptic drug primarily used for the treatment of refractory complex partial seizures and infantile spasms. While this medication has shown favorable efficacy in control...
503
Thursday, November 13th, 2025, 10:55
Precautions for Using Sabril (Vigabatrin)
Sabril (Vigabatrin) is an antiepileptic drug with unique efficacy in the treatment of refractory complex partial seizures and infantile spasms. This medication may cause severe adverse reactions, part...
506
Thursday, November 13th, 2025, 10:28
58 / 207
2065 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved